| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/06/2004 | US20040086942 Comprises peptide mimetic which competes for binding site of immunoglobulin receptor and prevents and treats allergic disorders |
| 05/06/2004 | US20040086937 Screening for antagonists and/or inhibitors of bacterial propagation and infection; mimetics |
| 05/06/2004 | US20040086899 Compromises nuclelotide sequences coding polypeptides associated with elongation of fatty acid chains for treatment and prevention of skin, cardiovascular, inflammatory, gastrointestinal, respiratory system and bone disorders |
| 05/06/2004 | US20040086877 Multi-mode directi memory access controller and method |
| 05/06/2004 | US20040086846 Using bacterial artificial chromosomes to propagate/replicate viral nucleotide sequences; gene therapy and genetic vaccines |
| 05/06/2004 | US20040086549 Advantage in using the silver ion as antiseptic agent is the general lack of formation of bacterial tolerance |
| 05/06/2004 | US20040086535 The use of anti-viral peptides for the reduction of virus infectivity and treatment of viral infection |
| 05/06/2004 | US20040086533 For inhibiting bacterial invasion via intestinal barrier containing live Bacillus subtilis cells as an active ingredient |
| 05/06/2004 | US20040086530 Transgenic plant or plant cell that, when consumed as a foodstuff in four or less feedings, elicits an anti-HBsAg boosting immune response that increases serum anti-HBsAg antibody levels at least four-fold |
| 05/06/2004 | US20040086527 Vaccine for conferring protection against human papillomavirus (HPV) infection in a human |
| 05/06/2004 | US20040086525 Polynucleotide sequences of C. pneumoniae for use in preventing and treating Chlamydia infection |
| 05/06/2004 | US20040086523 Fusion proteins of mycobacterium tuberculosis |
| 05/06/2004 | US20040086522 Strategies to prevent autoimmune disease by vaccination with vaccines based upon Epstein-Barr virus |
| 05/06/2004 | US20040086521 Method for the identification of antigenic peptides |
| 05/06/2004 | US20040086516 Inhibiting antigen presentation, comprising the step of supplying to an antigen-presenting cell, such as a dendritic cell, or precursor cell, a modulator, preferably an enhancer, of Toll-related receptor signalling |
| 05/06/2004 | US20040086514 Based on the finding of a specific Helicobacter pylori receptor in the human gastric epithelium; a glycolipid, lactotetraosylceramide, exclusively found in the human gastrointestinal tract |
| 05/06/2004 | US20040086512 Multimerization of HIV-1 VIF protein as a therapeutic target |
| 05/06/2004 | US20040086506 Polyvalent immunogen |
| 05/06/2004 | US20040086500 Murabutide, an analog of muramyl dipeptide, induces the production of cytokines or other factors not identified to date, which have a suppressor activity on HIV |
| 05/06/2004 | US20040086485 Viral vector sequences in plasmid form delivered in-vivo to generate vector producing cells |
| 05/06/2004 | US20040086479 Can be chemically modified for different biomedical applications such as tissue engineering applications, wound management, contrast agents vehicles, drug delivery vehicles, etc. |
| 05/06/2004 | EP1415994A1 Retinal pigmented epithelium derived neurotrophic factor |
| 05/06/2004 | EP1415990A1 Diazepan derivatives useful as factor X inhibitor |
| 05/06/2004 | EP1415983A1 5-amidino-n-(2-aminophenethyl)-hydroxybenzenesulfonamide derivative, medicinal composition containing the same, and intermediate therefor |
| 05/06/2004 | EP1415659A1 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 05/06/2004 | EP1415655A1 Immunotherapy for humans |
| 05/06/2004 | EP1414996A1 Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells |
| 05/06/2004 | EP1414961A2 Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression |
| 05/06/2004 | EP1414946A2 Dendritic cells and the uses thereof in screening cellular targets and potential drugs |
| 05/06/2004 | EP1414861A2 Humanized antibodies against icam-1, their production and uses |
| 05/06/2004 | EP1414858A2 Single chain camelid vhh antibodies, method for their production in a mammal, and their uses |
| 05/06/2004 | EP1414853A2 Method for studying the effects of commensal microflora on mammalian intestine and treatments of gastrointestinal-associated disease based thereon |
| 05/06/2004 | EP1414851A2 Cellular virus receptors and methods of use. |
| 05/06/2004 | EP1414849A2 Immune-modulating peptide |
| 05/06/2004 | EP1414841A1 Oligonucleotide-containing pharmacological compositions and their use |
| 05/06/2004 | EP1414836A2 Process for the preparation of l-ribavirin |
| 05/06/2004 | EP1414835A2 9a-n-[n'-(phenylsulfonyl)carbamoyl] derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin a and of 5-o-desosaminyl-9-deoxo-9-dihydro-9a-aza-9a-homoerythronolide a |
| 05/06/2004 | EP1414825A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 05/06/2004 | EP1414820A1 Non-nucleoside reverse transcriptase inhibitors |
| 05/06/2004 | EP1414812A1 Hydroxamic acid derivatives |
| 05/06/2004 | EP1414804A1 Acylsemicarbazides and their use as cyclin dependent kinase (cdk) inhibitors |
| 05/06/2004 | EP1414802A1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 05/06/2004 | EP1414801A1 Arylamines for the treatment of conditions associated with gsk-3 |
| 05/06/2004 | EP1414797A2 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 05/06/2004 | EP1414775A2 Novel bicyclic and tricyclic cannabinoids |
| 05/06/2004 | EP1414498A2 Stabilized formulations of interferons with sulfoalkyl ether cyclodextrins |
| 05/06/2004 | EP1414495A1 Anti-microbial targeting chimeric pharmaceutical |
| 05/06/2004 | EP1414490A1 Immunomodulatory oligonucleotide formulations and methods for use thereof |
| 05/06/2004 | EP1414481A2 Use of lhrh-antagonists for the improvement of t-cell mediated immunity |
| 05/06/2004 | EP1414470A1 Micronutrient phosphates as dietary and health supplements |
| 05/06/2004 | EP1414455A1 Isoquinoline inhibitors of p38 |
| 05/06/2004 | EP1414447A1 Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 05/06/2004 | EP1414444A1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 05/06/2004 | EP1414441A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 05/06/2004 | EP1414432A2 Methods of use for novel sulfur containing organic nitrate compounds |
| 05/06/2004 | EP1414428A1 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 05/06/2004 | EP1414415A2 Nutritional supplements and methods of using same |
| 05/06/2004 | EP1414316A1 Nutritional composition preventing bacterial overgrowth |
| 05/06/2004 | EP1326836B1 Process for making 3-amino-2-chloro-4-methylpyridine |
| 05/06/2004 | EP1268407B1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 05/06/2004 | EP1257548B1 Benzofuran carboxamides and their therapeutic use |
| 05/06/2004 | EP1163237B1 Amide derivatives |
| 05/06/2004 | EP1161438B1 6-o-substituted macrolides having antibacterial activity |
| 05/06/2004 | EP1134216B1 Anti-drug resistant strain agents and antichlamydia agents |
| 05/06/2004 | EP1123283B1 Thiazole-derivatives |
| 05/06/2004 | EP1056443B1 Butorphanol sustained release formulations |
| 05/06/2004 | EP1047395B1 Mixture containing honey, at least one essential oil and/or at least one essential oil derivative |
| 05/06/2004 | EP0999826B1 Self-emulsifying formulation for lipophilic compounds |
| 05/06/2004 | EP0980203A4 Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases |
| 05/06/2004 | EP0889955B1 Recombinant phages |
| 05/06/2004 | EP0812209B1 Cochleate delivery vehicles for biologically relevant molecules |
| 05/06/2004 | EP0729509B1 Vaccine against mumps containing a jeryl-lynn virus strain |
| 05/06/2004 | EP0589004B2 Process for the determination of peptides corresponding to immunologically important epitopes of hcv |
| 05/06/2004 | CA2511431A1 Pharmaceutical compositions comprising flavonoids and menthol |
| 05/06/2004 | CA2503471A1 1-acyl-pyrrolidine derivatives for the treatment of viral infections |
| 05/06/2004 | CA2502607A1 Method for treating erectile dysfunction and increasing libido in men |
| 05/06/2004 | CA2468903A1 Endogenous retrovirus up-regulated in prostate cancer |
| 05/05/2004 | CN1494554A Natural HIV virus antibody |
| 05/05/2004 | CN1494545A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors |
| 05/05/2004 | CN1494542A 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
| 05/05/2004 | CN1494541A Heterocyclic inhibitors of ERK 2 and uses thereof |
| 05/05/2004 | CN1494528A Benzophenones as inhibitors of reverse transcriptase |
| 05/05/2004 | CN1494433A Use of CD 23 antagonists for treatment of neoplastic disorders |
| 05/05/2004 | CN1494429A Aguatic animal treatment method and composition containing pimenta extract |
| 05/05/2004 | CN1494426A Bacterial translocation inhibitor and method of inhibiting bacterial translocation |
| 05/05/2004 | CN1494424A IL-8 receptor antagonists |
| 05/05/2004 | CN1494422A Use of GABAA inverse agonists in combination with nicotine receptor partial agonists, estrogen, selective estrogen modulators, or vitamin E for treatment of cognitive disorders |
| 05/05/2004 | CN1494374A Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof |
| 05/05/2004 | CN1493580A Ibuprofen ribavirin ester and preparation method and use thereof |
| 05/05/2004 | CN1493578A Preparation method of golden peach glycoside and its new use in medicine |
| 05/05/2004 | CN1493573A Production method of rifampicin isomer, rifampicin derivative and its mixture |
| 05/05/2004 | CN1493571A 木犀草素金属盐及其制备方法和用途 Luteolin and its preparation method and use salt |
| 05/05/2004 | CN1493568A Roxatiding bismuth citrate and its preparation method and use |
| 05/05/2004 | CN1493329A Chinese medicinal liquid for treating limb dermatomycosis |
| 05/05/2004 | CN1493324A Compound health protection liquid agent for external use and its preparation method |
| 05/05/2004 | CN1493320A Antivirus medicine for animal use |
| 05/05/2004 | CN1493315A Medicine for treating chronic hepatitis B |
| 05/05/2004 | CN1493306A Chinese medicine formulation of fungicide preparation |
| 05/05/2004 | CN1493301A Application of 6-methocy bideoxy bideoxy guanosine in preparation of antihepatitis B medicine |
| 05/05/2004 | CN1493297A Nebcin inhalation powder mist agent and its preparation method |